Skip to content

RX Mariakerke

Active
Private limited companyfounded 2023active for 3 yearsBrugsesteenweg 605, 9030 Gent, BelgiumKBO/BCE: BE 0802.273.340
Summary

RX Mariakerke has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€65,993) and a net result of -€67,993. Its solvency ranks better than 5% of 2,980 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Overview

Activity
Specialist medical practice
NACE 86220Medical imaging and medical laboratories NACE 86910
1 site
Size
€732,180total assets 2025
Staff
1.6 FTE
Equity
-€65,993
Loss
-€67,993
Turnover not published (abbreviated format)
Financial health
52 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
0.4%
Structure
Parent
Radiology Partners Europe · 100%
Accounts 18 days early3 of 4 deeds read
Why 52raises riskCapped at 59: negative equityNegative equity -€65,993lowers riskSector: Human health activities (NACE 86)Founded in 2023Size: 1.6 FTE, total assets €732,180Show the evidence

Checked score

Score 2025
52 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 6% of its sector peers (NACE 86, micro)
Negative equity caps the score at 59. Every signal that counts is listed under Signals.
Financial strength
Weak
Solvency 16
equity -9.0% of total assets
Liquidity 40
short-term debt 46.6% · cash 10.3%
Profitability 20
return on assets -9.3%
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,085 companies, NACE 86, micro)
Last 24 months 11-2024: 0.7% 12-2024: 0.7%● unchanged vs 11-2024 01-2025: 0.7%● unchanged vs 12-2024 02-2025: 0.8%▲ +0.1 percentage points vs 01-2025 03-2025: 0.7%▼ -0.1 percentage points vs 02-2025 04-2025: 0.7%● unchanged vs 03-2025 05-2025: 0.8%▲ +0.1 percentage points vs 04-2025 06-2025: 0.8%● unchanged vs 05-2025 07-2025: 0.8%● unchanged vs 06-2025 08-2025: 0.8%● unchanged vs 07-2025 09-2025: 0.8%● unchanged vs 08-2025highest value 10-2025: 0.8%● unchanged vs 09-2025highest value 11-2025: 0.6%▼ -0.2 percentage points vs 10-2025 12-2025: 0.6%● unchanged vs 11-2025 01-2026: 0.6%● unchanged vs 12-2025 02-2026: 0.6%● unchanged vs 01-2026 03-2026: 0.6%● unchanged vs 02-2026 04-2026: 0.6%● unchanged vs 03-2026 05-2026: 0.6%● unchanged vs 04-2026 06-2026: 0.3%▼ -0.3 percentage points vs 05-2026lowest value 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.3%● unchanged vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.4%▲ +0.1 percentage points vs 09-2026
No credit on open account
Liquidity insufficient (current ratio 0.54, below 1; short-term debt: 46.6% and cash: 10.3% of total assets), and equity is negative.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 3% on solvency, 10% on liquidity and 5% on profitability.

The bankruptcy probability was computed on 18-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Founded in 2023
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Negative equity -€65,993
NBB · annual accounts
lowers risk · Size: 1.6 FTE, total assets €732,180
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 13-10-2025, 18 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
18 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2023.
KBO publications · our coverage
  1. Amendment of the articlesGeneral meeting
  2. Annual accounts filedfinancial year 2025 · abbreviated…
  3. Resignations: NIELS FAVOREEL (director) and THOMAS…Appointment: BLOOM RX HOLDING BV…

Key points

  • Risk: Negative equityfinancial year 2025: debts exceed assets -€65,993 View
  • Caution: Among the weakest 5% on solvencysector median 58.8% · 2,980 companies -9.0% View
  • Controlled by Radiology Partners Europe 100% View

By topic

Financials

Financial year
2025
Total assets
€732,180
Loss
-€67,993
Solvency
-9.0%
Go to Financials

Board & ownership

Board
2 members
Parent
Radiology Partners Europe · 100%
  • Radiology Partners EuropeDirector
  • BLOOM RX HOLDING BVDirector
Go to Board & ownership

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
31-05-2023
Year ends
31-03
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.